| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb0eaf7da6b4e6867fd9a1f651d9f91d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-78 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-78 |
| filingDate |
2002-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_818ec9193fde0e69c38532d10ce225cc |
| publicationDate |
2003-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-10236631-A1 |
| titleOfInvention |
Methods and devices for the direct determination of the cyclase-inhibiting parathyroid hormone |
| abstract |
The present invention relates to novel methods and devices for directly determining the presence or amount of the cyclase inhibitory parathyroid hormone present in a clinical sample. Such determinations are useful to distinguish parathyroid diseases such as hyperparathyroidism from normal or non-disease. The target analyte is a large, incomplete parathyroid hormone peptide fragment that can act as a cyclase-activating parathyroid hormone antagonist. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8298770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7723042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7820393-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329409-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7892749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8470543-B2 |
| priorityDate |
2001-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |